Biểu đồ giá cổ phiếu HIND
HIND Dự đoán giá cổ phiếu
Vyome Holdings Inc
Quay lại
Vyome Holdings Inc (HIND) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$2.2
Giá mở cửa
$2.19
Phạm vi ngày
$2.08 - $2.21
Phạm vi 52 tuần
$1.75 - $46.6
Khối lượng
6.1K
Khối lượng trung bình
597.7K
Tỷ suất cổ tức
--
EPS (TTM)
63.63
Vốn hóa thị trường
$14.6M
HIND là gì?
Vyome Holdings, Inc. engages in the development of immuno-inflammatory assets. The company is headquartered in San Clemente, California and currently employs 9 full-time employees. The company went IPO on 2016-10-06. The firm is focused on leveraging its clinical-stage assets to transform the lives of patients with immuno-inflammatory conditions. Its clinical program VT1953 Gel is focused on cancer patients who are suffering from malignant fungating wounds (MFW). Its preclinical development program, VT1908, is a non-steroidal eye drop, which is focused on Uveitis. Its other business unit is focused on offering artificial intelligence (AI)-driven healthcare solutions across mental health and inflammation care, digital therapeutics and psychoneuroimmunology.
